Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Lung Neoplasms 3Solid Tumor 2Lymphatic Metastasis 2Prostatic Neoplasms 1Osteoporosis 1Melanoma 1Immunoglobulin Light-chain Amyloidosis 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Amyloidosis 1

Interventions

Zoledronic Acid 16Risedronic Acid 9Vitamin D 8Calcium 8Letrozole 7Absorptiometry, Photon 6Cholecalciferol 5Calcium Carbonate 5Alendronate 5Denosumab 4Calcium Gluconate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Progesterone 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Goserelin 2Estradiol 2Calcium Citrate 2Aromatase Inhibitors 2Anastrozole 2xian ling gu bao 1romosozumab 1X-Rays 1Toremifene 1Testosterone 1Technetium 1Spectrum Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteoporosis × Technetium × Clear all
NCT02304757 2021-11-17

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase NA Completed
142 enrolled 7 charts

Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡